ALT5 Sigma Corporation (NASDAQ:ALTS - Get Free Report)'s share price shot up 6.5% on Wednesday . The company traded as high as $7.68 and last traded at $7.66. 210,758 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 234,322 shares. The stock had previously closed at $7.19.
ALT5 Sigma Trading Down 1.2%
The company has a debt-to-equity ratio of 1.26, a current ratio of 0.83 and a quick ratio of 0.83. The business's 50-day simple moving average is $8.13 and its two-hundred day simple moving average is $6.27.
ALT5 Sigma Company Profile
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
Featured Stories
Before you consider ALT5 Sigma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ALT5 Sigma wasn't on the list.
While ALT5 Sigma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
